Short-term treatment with the GABAAreceptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome

  • Pentylenetetrazole as a pro-cognitive therapy in Down's syndrome
  • D Colas, B Chuluun, D Warrier, M Blank, D Z Wetmore, P Buckmaster, C C Garner, H C Heller
  • British Journal of Pharmacology, June 2013, Wiley
  • DOI: 10.1111/bph.12169

The authors haven't yet claimed this publication.

Read Publication

In partnership with:

Link to Wiley showcase